Proteomic profiling reveals the transglutaminase-2 externalization pathway in kidneys after unilateral ureteric obstruction

Furini, G ORCID logoORCID: https://orcid.org/0000-0001-7206-7720, Schroeder, N, Huang, L, Boocock, D ORCID logoORCID: https://orcid.org/0000-0002-7333-3549, Scarpellini, A, Coveney, C ORCID logoORCID: https://orcid.org/0000-0001-7047-6408, Tonoli, E ORCID logoORCID: https://orcid.org/0000-0001-9774-1048, Ramaswamy, R, Ball, G ORCID logoORCID: https://orcid.org/0000-0001-5828-7129, Verderio, C, Johnson, TS and Verderio, EAM ORCID logoORCID: https://orcid.org/0000-0001-9153-8997, 2018. Proteomic profiling reveals the transglutaminase-2 externalization pathway in kidneys after unilateral ureteric obstruction. Journal of the American Society of Nephrology, 29 (3), pp. 880-905. ISSN 1046-6673

[thumbnail of PubSub10333_Verderio-Edwards.pdf]
Preview
Text
PubSub10333_Verderio-Edwards.pdf - Published version

Download (4MB) | Preview

Abstract

Increased export of transglutaminase-2 (TG2) by tubular epithelial cells (TECs) into the surrounding interstitium modifies the extracellular homeostatic balance, leading to fibrotic membrane expansion. Although silencing of extracellular TG2 ameliorates progressive kidney scarring in animal models of CKD, the pathway through which TG2 is secreted from TECs and contributes to disease progression has not been elucidated. In this study, we developed a global proteomic approach to identify binding partners of TG2 responsible for TG2 externalization in kidneys subjected to unilateral ureteric obstruction (UUO) using TG2 knockout kidneys as negative controls. We report a robust and unbiased analysis of the membrane interactome of TG2 in fibrotic kidneys relative to the entire proteome after UUO, detected by SWATH mass spectrometry. The data have been deposited to the ProteomeXchange with identifier PXD008173. Clusters of exosomal proteins in the TG2 interactome supported the hypothesis that TG2 is secreted by extracellular membrane vesicles during fibrosis progression. In established TEC lines, we found TG2 in vesicles of both endosomal (exosomes) and plasma membrane origin (microvesicles/ectosomes), and TGF-β1 stimulated TG2 secretion. Knockout of syndecan-4 (SDC4) greatly impaired TG2 exosomal secretion. TG2 coprecipitated with SDC4 from exosome lysate but not ectosome lysate. Ex vivo, EGFP-tagged TG2 accumulated in globular elements (blebs) protruding/retracting from the plasma membrane of primary cortical TECs, and SDC4 knockout impaired bleb formation, affecting TG2 release. Through this combined in vivo and in vitro approach, we have dissected the pathway through which TG2 is secreted from TECs in CKD.

Item Type: Journal article
Publication Title: Journal of the American Society of Nephrology
Creators: Furini, G., Schroeder, N., Huang, L., Boocock, D., Scarpellini, A., Coveney, C., Tonoli, E., Ramaswamy, R., Ball, G., Verderio, C., Johnson, T.S. and Verderio, E.A.M.
Publisher: American Society of Nephrology
Date: March 2018
Volume: 29
Number: 3
ISSN: 1046-6673
Identifiers:
Number
Type
10.1681/ASN.2017050479
DOI
660429
Other
Divisions: Schools > School of Science and Technology
Record created by: Linda Sullivan
Date Added: 26 Feb 2018 14:26
Last Modified: 04 Feb 2022 14:24
URI: https://irep.ntu.ac.uk/id/eprint/32802

Actions (login required)

Edit View Edit View

Statistics

Views

Views per month over past year

Downloads

Downloads per month over past year